The Impella group required transfusion of 2.6 U packed red blood cells versus 1.2 U in the IABP group (p = 0.18). Among patients with cardiogenic shock due to AMI, the Impella device resulted in a ...

For 5 weeks, the tiny Impella kept Katrina Penney's failed heart pumping while a second heart transplant was secured.

"Her heart was barely moving, and she was in cardiogenic shock," he said ... Okere inserted a small device called an Impella, a tiny heart pump designed to help pump blood through her heart.

Further studies are warranted to investigate the outcomes according to the cause of the cardiogenic shock, learning curves for Impella use, and readmissions in patients who received the Impella. The ...

Although mortality risk prediction in cardiogenic shock (CS) is possible ... Consecutive CS patients supported by pVAD Impella (Abiomed, Danvers, MA) at two national referral centers were included.

The following is a summary of “Corticosteroids in Cardiogenic Shock: A Retrospective Analysis of the Medical Information Mart ...

The following is a summary of “Patient Characteristics, Management and Long-term Outcomes of Patients with Cardiogenic Shock ...

Despite advances in the treatment of myocardial infarction (MI), the incidence of cardiogenic shock has remained at 7% to 10% during the last 25 years. Hospital mortality was about 90% in the ...

Discover how heart centers across the country are improving patient outcomes and reducing mortality rates through innovative approaches and advanced therapies.

But first, some lessons learned. If this was forwarded to you, sign up here. Preparing for next time It was the shock heard around the world until it wasn't. DeepSeek's arrival hit the market ...